370 related articles for article (PubMed ID: 23071261)
1. Molecular pathways: understanding the role of Rad52 in homologous recombination for therapeutic advancement.
Lok BH; Powell SN
Clin Cancer Res; 2012 Dec; 18(23):6400-6. PubMed ID: 23071261
[TBL] [Abstract][Full Text] [Related]
2. RAD52 inactivation is synthetically lethal with deficiencies in BRCA1 and PALB2 in addition to BRCA2 through RAD51-mediated homologous recombination.
Lok BH; Carley AC; Tchang B; Powell SN
Oncogene; 2013 Jul; 32(30):3552-8. PubMed ID: 22964643
[TBL] [Abstract][Full Text] [Related]
3. Replication Protein A Phosphorylation Facilitates RAD52-Dependent Homologous Recombination in BRCA-Deficient Cells.
Carley AC; Jalan M; Subramanyam S; Roy R; Borgstahl GEO; Powell SN
Mol Cell Biol; 2022 Feb; 42(2):e0052421. PubMed ID: 34928169
[TBL] [Abstract][Full Text] [Related]
4. Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile.
Cramer-Morales K; Nieborowska-Skorska M; Scheibner K; Padget M; Irvine DA; Sliwinski T; Haas K; Lee J; Geng H; Roy D; Slupianek A; Rassool FV; Wasik MA; Childers W; Copland M; Müschen M; Civin CI; Skorski T
Blood; 2013 Aug; 122(7):1293-304. PubMed ID: 23836560
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Tumor Cells.
Sullivan-Reed K; Bolton-Gillespie E; Dasgupta Y; Langer S; Siciliano M; Nieborowska-Skorska M; Hanamshet K; Belyaeva EA; Bernhardy AJ; Lee J; Moore M; Zhao H; Valent P; Matlawska-Wasowska K; Müschen M; Bhatia S; Bhatia R; Johnson N; Wasik MA; Mazin AV; Skorski T
Cell Rep; 2018 Jun; 23(11):3127-3136. PubMed ID: 29898385
[TBL] [Abstract][Full Text] [Related]
6. Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins.
Prakash R; Zhang Y; Feng W; Jasin M
Cold Spring Harb Perspect Biol; 2015 Apr; 7(4):a016600. PubMed ID: 25833843
[TBL] [Abstract][Full Text] [Related]
7. Selective killing of homologous recombination-deficient cancer cell lines by inhibitors of the RPA:RAD52 protein-protein interaction.
Al-Mugotir M; Lovelace JJ; George J; Bessho M; Pal D; Struble L; Kolar C; Rana S; Natarajan A; Bessho T; Borgstahl GEO
PLoS One; 2021; 16(3):e0248941. PubMed ID: 33784323
[TBL] [Abstract][Full Text] [Related]
8. Dynamic regulatory interactions of rad51, rad52, and replication protein-a in recombination intermediates.
Sugiyama T; Kantake N
J Mol Biol; 2009 Jul; 390(1):45-55. PubMed ID: 19445949
[TBL] [Abstract][Full Text] [Related]
9. The endonuclease EEPD1 mediates synthetic lethality in RAD52-depleted BRCA1 mutant breast cancer cells.
Hromas R; Kim HS; Sidhu G; Williamson E; Jaiswal A; Totterdale TA; Nole J; Lee SH; Nickoloff JA; Kong KY
Breast Cancer Res; 2017 Nov; 19(1):122. PubMed ID: 29145865
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Rad51 recombinase presynaptic filament assembly via interactions with the Rad52 mediator and the Srs2 anti-recombinase.
Seong C; Colavito S; Kwon Y; Sung P; Krejci L
J Biol Chem; 2009 Sep; 284(36):24363-71. PubMed ID: 19605344
[TBL] [Abstract][Full Text] [Related]
11. Protein dynamics during presynaptic-complex assembly on individual single-stranded DNA molecules.
Gibb B; Ye LF; Kwon Y; Niu H; Sung P; Greene EC
Nat Struct Mol Biol; 2014 Oct; 21(10):893-900. PubMed ID: 25195049
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic exploitation of tumor cell defects in homologous recombination.
Powell SN; Kachnic LA
Anticancer Agents Med Chem; 2008 May; 8(4):448-60. PubMed ID: 18473729
[TBL] [Abstract][Full Text] [Related]
13. Spatiotemporal dynamics of homologous recombination repair at single collapsed replication forks.
Whelan DR; Lee WTC; Yin Y; Ofri DM; Bermudez-Hernandez K; Keegan S; Fenyo D; Rothenberg E
Nat Commun; 2018 Sep; 9(1):3882. PubMed ID: 30250272
[TBL] [Abstract][Full Text] [Related]
14. The function of RAD52 N-terminal domain is essential for viability of BRCA-deficient cells.
Hanamshet K; Mazin AV
Nucleic Acids Res; 2020 Dec; 48(22):12778-12791. PubMed ID: 33275133
[TBL] [Abstract][Full Text] [Related]
15. Small-Molecule Disruption of RAD52 Rings as a Mechanism for Precision Medicine in BRCA-Deficient Cancers.
Chandramouly G; McDevitt S; Sullivan K; Kent T; Luz A; Glickman JF; Andrake M; Skorski T; Pomerantz RT
Chem Biol; 2015 Nov; 22(11):1491-1504. PubMed ID: 26548611
[TBL] [Abstract][Full Text] [Related]
16. Recovery of deficient homologous recombination in Brca2-depleted mouse cells by wild-type Rad51 expression.
Lee SA; Roques C; Magwood AC; Masson JY; Baker MD
DNA Repair (Amst); 2009 Feb; 8(2):170-81. PubMed ID: 18992372
[TBL] [Abstract][Full Text] [Related]
17. A moving target for drug discovery: Structure activity relationship and many genome (de)stabilizing functions of the RAD52 protein.
Bhat DS; Spies MA; Spies M
DNA Repair (Amst); 2022 Dec; 120():103421. PubMed ID: 36327799
[TBL] [Abstract][Full Text] [Related]
18. RAD52 influences the effect of BRCA1/2 missense variants on homologous recombination and gene reversion in Saccharomyces cerevisiae.
Lodovichi S; Bellè F; Mercatanti A; Spugnesi L; Cozzani C; Caligo MA; Cervelli T; Galli A
FEMS Yeast Res; 2022 Jun; 22(1):. PubMed ID: 35472165
[TBL] [Abstract][Full Text] [Related]
19. Effect of the expression of BRCA2 on spontaneous homologous recombination and DNA damage-induced nuclear foci in Saccharomyces cerevisiae.
Spugnesi L; Balia C; Collavoli A; Falaschi E; Quercioli V; Caligo MA; Galli A
Mutagenesis; 2013 Mar; 28(2):187-95. PubMed ID: 23328489
[TBL] [Abstract][Full Text] [Related]
20. Pan-cancer analysis of co-occurring mutations in RAD52 and the BRCA1-BRCA2-PALB2 axis in human cancers.
Hamid AB; Frank LE; Bouley RA; Petreaca RC
PLoS One; 2022; 17(9):e0273736. PubMed ID: 36107942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]